TechTarsFinancial Intelligence

Navigate

Browse & analyze

Why Nifty, Sensex & S&P moved

SIP, EMI, FD & more

Your saved stocks

Account

Disclaimer: TechTars provides educational analytics and financial tools for informational purposes only. Nothing on this platform constitutes investment advice, financial advice, or trading recommendations. TechTars is not a SEBI-registered investment adviser or research analyst, and no content here is a recommendation to buy, sell, or hold any security. Always consult a qualified, SEBI-registered financial advisor before making investment decisions.

TechTars

Structured financial intelligence.
No tips. No noise. Just data.

Product

Indian Stocks
US Stocks
Market Indices
SIP Calculator
Blog & Guides

Legal

Privacy Policy
Terms of Service
Disclaimer

🔒Your data stays private

© 2026 TechTars.com

Market data delayed by ~15 minutes. Not investment advice.

Home
/
Indian Stocks
/
Divi's Laboratories vs Biocon

Divi's Laboratories vs Biocon

Side-by-side stock comparison - today's price, technicals, and structured verdict.

More Indian stock comparisons

→HDFC Bank vs ICICI Bank →ICICI Bank vs Axis Bank →State Bank of India vs HDFC Bank →Kotak Mahindra Bank vs Axis Bank →State Bank of India vs Bank of Baroda →Tata Consultancy Services vs Infosys

Written by Yadav Patle· Founder, TechTars · 7+ years tracking Indian & US markets

•

Last updated: 8 September 2026 at 1:34 pm IST

•How we analyse stocksFounder, TechTars · 7+ years tracking Indian & US markets

Divi's Laboratories (DIVISLAB) is up 2.00% while Biocon (BIOCON) is up 0.61% on the NSE/BSE. Today, Divi's Laboratories is outperforming on a percentage basis.

Divi's LaboratoriesDIVISLAB

₹9501.50

+2.00%

VS

₹393.80

+0.61%

Divi's Laboratories vs Biocon: today's numbers

₹9501.50

Price

₹393.80

+2.00%

Today

+0.61%

59/100Moderate

TechTars Score

58/100Moderate

Bullish

Market bias

Neutral

Bullish

Sentiment

Neutral

72 (overbought)

RSI

33 (neutral)

Uptrend

Trend

Downtrend

-

MACD

-

₹9100.00

Support

₹388.80

₹9505.17

Resistance

₹404.05

High

Confidence

Medium

Why Divi's Laboratories moved today

DIVISLAB.NS rose 2.00%. No specific company news was reported to explain the gain.

Why Biocon moved today

BIOCON.NS rose 0.61% on news of a 10-year Pertuzumab partnership in Brazil for breast cancer therapy.

Read full Divi's Laboratories analysis Read full Biocon analysis

This side-by-side comparison of DIVISLAB and BIOCON is generated from publicly available price, volume, and news data using the methodology at /methodology/stock-analysis. It is educational context, not a recommendation to buy or sell either stock, and does not say which is a "better" investment. Prices and indicators change minute-to-minute. Consult a SEBI-registered investment adviser before acting on any of this information.